Conference

TSCA Developments 2020

16 Jul 2020Virtual conference (+ video recordings)

Find out what the latest TSCA updates mean for you and your business

TSCA Developments 2020

This event is now available on demand. Please contact events@chemicalwatch.com for pricing and access. You can also find more recent editions of this event on our Events Portal.

Agenda

11:00 GMT

Welcome and introduction

Moderator:

Terry Hyland, Chemical Watch News & Insight, Enhesa Product Intelligence

11:01 GMT

Session one: Regulatory updates

11:10 GMT

Keynote: TSCA Updates from the EPA

Alexandra Dapolito Dunn, Baker Botts

11:35 GMT

TSCA chemical data reporting (CDR) 2020: Something old, something new

  • Update on the current reporting window
  • Update on the small business definition

Jeff Hafer, knoell USA, United States

12:00 GMT

TSCA fees

  • Upcoming rulemaking on fee exemptions
  • Overview of self-identification process
  • Strategies for payment: How are consortia dividing up fees between participants?

Lynn L. Bergeson, Bergeson & Campbell, USA

12:20 GMT

Q&A

12:35 GMT

TSCA new chemical programme

  • Changes under the LCSA
  • Their Impact on the Chemical Industry
  • Practical Considerations and Recommendations

John J. Kowalski, UL Solutions, USA

12:55 GMT

TSCA new chemical programme statistics and pre-manufacture notice (PMN) status

  • Programme statistics: update on PMN 'backlog' and EPA new chemical review efforts
  • A reflection on PMN submissions since the new higher fees took effect

Devin Millions, Exponent

13:15 GMT

Q&A

13:30 GMT - 14:00 GMT

Chemical Watch platform and service demonstration

Tassia Agatowski, Chemical Watch

13:30 GMT

Break

13:39 GMT

Session two: Risk management and evaluation

14:15 GMT

A reflection on recent risk evaluations: NGO perspective

Is the EPA risk evaluation process effectively protecting the public?

  • The impact of the SACC peer review process
  • Gaps in the EPA evaluations
  • Important policy and legal issues

Bob Sussman, Sussman and Associates, United States

14:40 GMT

Preview of emerging issues on the next 20 risk evaluations: Lessons learned from the first 10

  • Should we expect the EPA to issue test orders and make other efforts to fill data gaps? 
  • What role are industry consortia playing in this process?

Herb Estreicher, Keller and Heckman LLP, United States

15:00 GMT

Q&A

15:10 GMT

Session three: Confidential business information (CBI) under TSCA, enforcement and litigation

15:15 GMT

CBI substantiation overview

  • Issues that could cause the EPA to drop a chemical identity confidentiality claim and what recourse companies have to stop this
  • An insight into CBI’s upfront substantiation requirements

Erik Baptist, Wiley Rein LLP

15:35 GMT

Enforcement and litigation issues including enforcement during the Covid-19 pandemic

Sara Beth Watson, Steptoe and Johnson LLP

15:55 GMT

Q&A

16:10 GMT

Break

16:25 GMT

Session four: Stakeholder perspectives and outlooks

16:30 GMT

Covid 19 – the impact of the coronavirus on TSCA

16:50 GMT

Reflections on four years of implementing the Lautenberg Amendments: a former EPA insider’s perspective and advice

Erik Baptist, Wiley Rein LLP

17:15 GMT

Stakeholder panel: A look to the future

Richard Engler, Bergeson & Campbell, PC; Jeff Hafer, knoell USA, United States; Erik Baptist, Wiley Rein LLP

17:40 GMT

Q&A and conference wrap-up

Chemical Watch